Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease

British Journal of Haematology

Volumn 104, Issue 2, 1999, Pages 246-257

  Woodward, Mark ^b   Rumley, Ann ^b   Tunstall Pedoe, Hugh ^b   Lowe, Gordon D O ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b NONE

Author keywords

Cardiovascular disease; Interleukin 6; Viscosity

Indexed keywords

FIBRINOGEN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ALCOHOL DRINKING; BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; CONTRACEPTIVES, ORAL; FEMALE; HEMORHEOLOGY; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS; SMOKING;

EID: 0032912784     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01158.x     Document Type: Article

References (43)

1. Baker, I.A., Sweetnam, P.M., Yarnell, J.W.G., Bainton, D. & Elwood, P.C. (1988) Hemostatic and other risk factors for ischaemic heart disease and social class; evidence from the Caerphilly and Speedwell studies. International Journal of Epidemiology, 17, 759-765.
2. Baumann, H. & Gauldie, J. (1990) Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other of inflammation. Molecular Biology and Medicine, 7, 147-159.
3. Bottiger, L.E. & Carlsson, L.A. (1980) Risk factors for ischaemic vascular death for men in the Stockholm prospective study. Atherosclerosis, 36, 389-408.
4. Chae, C.U., Ridker, P.M. & Manson, J.E. (1997) Postmenopausal hormone replacement therapy and cardiovascular disease. Thrombosis and Haemostasis, 78, 770-780.
5. Crombie, I.K., Smith, W.C.S., Irving, J.M. & Tunstall-Pedoe, H.D. (1989) Experience with general practitioner lists as a sampling frame for a survey of cardiovascular risk factors. The Statistician, 38, 25-31.
6. Dalmon, J., Laurent, M. & Courtois, G. (1993) The human β fibrinogen promoter contains hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Molecular and Cellular Biology, 13, 1183-1193.
7. Danesh, J., Collins R., Appleby, P. & Peto, R. (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Journal of the American Medical Association, 279, 1477-1482.
8. Ernst, E., Hammerschmidt, D.E., Bagge, U., Matrai, A. & Dormandy, J.A. (1987) Leukocytes and the risk of ischemic diseases. Journal of the American Medical Association, 257, 2318-2324.
9. Ernst, E. & Resch, K.L. (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Annals of Internal Medicine, 118, 956-963.
10. Fowkes, F.G.R., Lowe, G.D.O., Rumley, A., Lennie, S.E., Smith, F.B. & Donnan, P.T. (1993) Relation of blood viscosity to blood pressure in a random sample of the population aged 55-74 years. European Heart Journal, 14, 597-601.
11. Fröhlich, M., Schunkert, H., Hense, H.-W., Tropitzsch, A., Hendricks, P., Döring, A., Riegger, G.A.J. & Koenig, W. (1998) Effects of hormone replacement therapies on fibrinogen and plasma viscosity in postmenopausal women. British Journal of Haematology, 100, 577-581.
12. Gaffney, P.J. & Wong, M.T. (1992) Collaborative study of a proposed international standard for plasma fibrinogen measurement. Thrombosis and Haemostasis, 68, 428-432.
13. Gagnon, D.R., Zhang, T.-J., Brand, F.N. & Kannel, W.B. (1994) Hematocrit and the risk of cardiovascular disease - the Framingham Study: a 34-year follow-up. American Heart Journal, 127, 674-682.
14. Gillum, R.F., Mussolino, M.E. & Makue, D.M. (1995) Erythrocyte sedimentation rate and coronary heart disease: the NHANES I epidemiologic follow-up study. Journal of Clinical Epidemiology, 48, 353-361.
15. Helmerhorst F.M., Bloemenkamp, K.W.M., Rosendaal, F.R. & Vandenbroucke, J.P. (1997) Oral contraceptives and thrombotic disease: risk of venous thromboembolism. Thrombosis and Haemostasis, 78, 327-333.
16. Khaw, K.T. & Woodhouse, P. (1995) Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. British Medical Journal 310, 1559-1563.
17. Koenig, W., Sund, M., Ernst, E., Keil, U., Rosenthal, J. & Hombach, V. (1992a) Assocation between plasma viscosity and blood pressure: results from the MONICA-Project Augsburg. American Journal of Hypertension, 4, 529-536.
18. Koenig, W., Sund, M., Ernst, E., Mraz, W., Hombach, V. & Keil, U. (1992b) Association between rheology and components of lipoproteins in human blood. Circulation, 85, 2197-2204.
19. Le, J. & Vilcek, J. (1989) Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein sequence. Laboratory Investigation, 61, 588-602.
20. Lee, A.J., Lowe, G.D.O., Smith, W.C.S. & Tunstall-Pedoe, H. (1993) Plasma fibrinogen in women; relationships with oral contraception, the menopause and hormone replacement therapy. British Journal of Haematology, 83, 616-621.
21. Leng, G.C. & Fowkes, F.G.R. (1992) The Edinburgh Claudication Questionnaire: an improved version of the WHO Rose questionnaire for use in epidemiologic surveys. Journal of Clinical Epidemiology, 45, 1101-1109.
22. Lowe, G.D.O. (1994) Blood rheology, haemostasis and vascular disease. Haemostasis and Thrombosis, 3rd edn (ed. by A. L. Bloom, C. D. Forbes, D. P. Thomas and E. G. D. Tuddenham), pp. 1169-1188. Churchill Livingstone, Edinburgh.
23. Lowe, G.D.O., Drummond, M.M., Forbes, C.D. & Barbenel, J.C. (1980) Increased blood viscosity in young women using oral contraceptives. American Journal of Obstetrics and Gynecology, 137, 840-842.
24. Lowe, G.D.O., Fowkes, F.G.R., Dawes, J., Donnan, P.T., Lennie, S.E., & Housley, E. (1993a) Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation, 87, 1915-1920.
25. Lowe, G.D.O., Lee, A.J., Rumley, A., Price, J.F. & Fowkes, F.G.R. (1997a) Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. British Journal of Haematology, 96, 168-173.
26. Lowe, G.D.O., Lee, A.J., Rumley, A., Smith, W.C.S. & Tunstall-Pedoe, H. (1992) Epidemiology of haematocrit, white cell count, red cell aggregation and fibrinogen: the Glasgow MONICA study. Clinical Hemorheology, 12, 535-544.
27. Lowe, G.D.O., Rumley, A., Lee, A.J., Crilly, A., Madhok, R. & Tunstall-Pedoe, H.D. (1993b) Correlation of plasma fibrinogen, plasminogen activator inhibitor, and red cell aggregation with interleukin-6 levels in a population study. (Abstract). Thrombosis and Haemostasis, 69, 763.
28. Lowe, G.D.O., Rumley, A., Woodward, M., Morrison, C.E., Philippou, H., Lane, D.A. & Tunstall-Pedoe, H. (1997b) Epidemiology of coagulation factors, inhibitors and activation markers: Glasgow MONICA Study. I. Illustrative reference ranges by age, sex, and hormone use. British Journal of Haematology, 97, 775-784.
29. Lowe, G.D.O., Smith, W.C.S., Tunstall-Pedoe, H.D., Crombie, I.K., Lennie, S.E., Anderson, J. & Barbenel, J.C. (1988) Cardiovascular risk and haemorheology: results from the Scottish Heart Health Study and the MONICA Project, Glasgow. Clinical Hemorheology, 8, 517-524.
30. McRury, S.M., Lennie, S.E., McColl, P., Balendra, R., MacCuish, A.C. & Lowe, G.D.O. (1993) Increased red cell aggregation in diabetes mellitus: association with cardiovascular risk factors. Diabetic Medicine, 10, 21-26.
31. Office of Population Censuses and Surveys (1980) Classification of Occupations, 1980. HMSO, London.
32. Prineas, R.J., Crow, R.S. & Blackburn, H. (1982) The Minnesota Code Manual of Electrocardiographic Findings. John Wright, Bristol.
33. Rose, G., McCartney, P. & Reid, D.D. (1977) Self-administration of a questionnaire on chest pain and intermittent claudication. British Journal of Preventive and Social Medicine, 31, 42-48.
34. Rumley, A., Lowe, G.D.O., Norrie, J., Ford, I., Shepherd, J. & Cobbe, S.M., for the West of Scotland Coronary Prevention Study Group (1997) Blood rheology and outcome in the West of Scotland Coronary Prevention Study: is the benefit of lipoprotein reduction partly due to lower viscosity? (Abstract). British Journal of Haematology, 97, (Suppl. 1), 78.
35. Smith, W.C.S., Lowe, G.D.O., Lee, A.J. & Tunstall-Pedoe, H. (1992) Rheological determinants of blood pressure in a Scottish adult population. Journal of Hypertension, 10, 467-472.
36. Smith, W.C.S., Tunstall-Pedoe, H., Crombie, I.K. & Tavendale, R. (1989) Concomitants of excess coronary deaths: major risk factor and life-style findings from 10,359 men and women in the Scottish heart health study. Scottish Medical Journal, 34, 550-555.
37. Thorogood, M. (1997) Oral contraceptives and myocardial infarction: new evidence leaves unanswered questions. Thrombosis and Haemostasis, 78, 334-338.
38. Vuilleumier, J.P. & Keck, E. (1989) Fluorometric assay of vitamin C in biological samples using a centrifugal analyser with fluorescence attachment. Journal of Micronutrient Analysis, 5, 25-34.
39. Wannamethee, G., Shaper, A.G. & Whincup, P.H. (1994) Ischaemic heart disease: association with haematocrit in the British Regional Heart Study. Journal of Epidemiology and Community Health, 48, 112-118.
40. Woodward, M., Lowe, G.D.O., Rumley, A., Tunstall-Pedoe, H., Philippou, H., Lane, D.A. & Morrison, C.E. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Study. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology, 97, 785-797.
41. Woodward, M., Tunstall-Pedoe, H., Smith, W.C.S. & Tavendale, R. (1991) Smoking characteristics and inhalation biochemistry in the Scottish population. Journal of Clinical Epidemiology, 44, 1405-1410.
42. World Health Organization Principal Investigators (prepared by H. Tunstall-Pedoe) (1988) The World Health Organisation MONICA Project (Monitoring trends and determinants in cardiovascular disease): a major international collaboration. Journal of Clinical Epidemiology, 41, 105-113.
43. Yarnell, J.W.G., Baker, I.A., Sweetman, P.M., Bainton, D., O'Brien, J.R., Whitehead, P.J. & Elwood, P.C. (1991) Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation, 83, 836-844.